Publication | Closed Access

New bis([1,2,4]triazolo)[4,3-a:3′,4′-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation

Molecular PharmacologyMedicinal ChemistryDiversity Oriented SynthesisMedicineVegfr-2 InhibitorsNew BisAnticancer EvaluationPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug Discovery